Brief: Bioventus Q2 Adjusted EPS USD 0.19
06/08/2024 12:30
Aug 06 (Reuters) - Bioventus Q2 adjusted EBITDA USD 34.5 million. * Q2 sales USD 151.2 million
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks